tera.ai

Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

All entities

Entity

CAD-2000

product1 mentionslast seen Oct 7, 2026

Preclinical, next-generation, orally bioavailable 12-lipoxygenase inhibitor under development as an outpatient Immunology & Inflammation platform.

Relationships 2

CAD-2000

Relationship

Cadrenal Therapeutics, Inc.developsCAD-2000

93% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1